Projects per year
Fingerprint Dive into the research topics where Raymond Bergan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
Genistein
Medicine & Life Sciences
Prostate
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Neoplasm Metastasis
Medicine & Life Sciences
Cell Movement
Medicine & Life Sciences
Oligodeoxyribonucleotides
Medicine & Life Sciences
Suramin
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1977 2020
SPORE in Prostate Cancer
Bergan, R., Jindan, Y., Kaul, K. L., Catalona, W., Jovanovic, B., Abdulkadir, S. A. & Szmulewitz, R.
8/18/15 → 7/31/20
Project: Research project
Research Personnel
Prostatic Neoplasms
Mentors
Research
Publications
Cell Movement
Neoplasm Metastasis
Prostatic Neoplasms
Phosphorylation
Neoplasms
Genistein-mediated Regulation of Prostate Cancer Cell Motility
9/23/08 → 7/31/14
Project: Research project
Genistein
Cell Movement
Prostatic Neoplasms
HSP27 Heat-Shock Proteins
Prostate
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
Bergan, R. & Bergan, R.
9/30/03 → 9/29/12
Project: Research project
Prostate
Genistein
Prostatic Neoplasms
Cell Survival
Growth
Research Output 1991 2019
1
Citation
(Scopus)
Genistein treatment duration effects biomarkers of cell motility in human prostate
Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 1 2019, In : PloS one. 14, 3, e0214078.Research output: Contribution to journal › Article
Open Access
Genistein
genistein
Biomarkers
cell movement
Cell Movement
Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells
Li, Y., Guo, Y., Feng, Z., Bergan, R., Li, B., Qin, Y., Zhao, L., Zhang, Z. & Shi, M., Jan 1 2019, In : Nutrition and Cancer.Research output: Contribution to journal › Article
Phosphatidylinositol 3-Kinases
Drug Resistance
Doxorubicin
Cell Line
HL-60 Cells
Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential (ESP) Charges
Mishra, R. K., Deibler, K. K., Clutter, M. R., Vagadia, P. P., O'Connor, M., Schiltz, G. E., Bergan, R. & Scheidt, K. A., Jan 1 2019, (Accepted/In press) In : Journal of Chemical Information and Modeling.Research output: Contribution to journal › Article
Electrostatics
activity structure
Phosphotransferases
non-alignment
predictive model
Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization
Thrivikraman, G., Athirasala, A., Gordon, R., Zhang, L., Bergan, R., Keene, D. R., Jones, J. M., Xie, H., Chen, Z., Tao, J., Wingender, B., Gower, L., Ferracane, J. & Bertassoni, L., Dec 1 2019, In : Nature communications. 10, 1, 3520.Research output: Contribution to journal › Article
Open Access
Biomimetics
biomimetics
collagens
bones
Bone
1
Citation
(Scopus)
Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors
Deibler, K. K., Schiltz, G. E., Clutter, M. R., Mishra, R. K., Vagadia, P. P., O'Connor, M., George, M. D., Gordon, R., Fowler, G., Bergan, R. & Scheidt, K. A., Jan 1 2019, In : ChemMedChem.Research output: Contribution to journal › Article
MAP Kinase Kinase 4
Benzoic Acid
Molecular modeling
Oncology
p38 Mitogen-Activated Protein Kinases